SCHEDULE 13D/A: Cosmos Health CEO Grigorios Siokas Boosts Stake to 16.6% Through Debt-for-Equity Conversions

Cosmos Health Inc. CEO Grigorios Siokas has increased his beneficial ownership in the company to 16.6% through a series of debt-for-equity exchange agreements, as detailed in a recent Schedule 13D amendment.

Summary

• Grigorios Siokas, the Chief Executive Officer of Cosmos Health Inc., now beneficially owns 4,609,399 shares of the company's common stock, representing 16.6% of the class.
• This ownership percentage is calculated based on 26,979,875 shares issued and outstanding as of February 26, 2025.
• Mr. Siokas's holdings include 3,897,016 currently issued shares, 212,383 shares issuable upon exercise of Exchange Warrants issued on October 20, 2022, and 500,000 shares issuable upon exercise of Series B Common Warrants exercisable at $3.00 per share.
• He acquired additional shares through four separate Debt Exchange Agreements, converting company debt owed to him into equity.
• On January 30, 2024, he acquired 51,414 shares at an exchange rate of $0.6613 per share, converting $34,000 of debt.
• On February 11, 2024, he acquired 108,510 shares at an exchange rate of $0.6451 per share, converting $70,000 of debt.
• On February 13, 2025, he acquired 70,313 shares at an exchange rate of $0.64 per share, converting $45,000 of debt.
• On February 24, 2025, he acquired 354,296 shares at an exchange rate of $0.5645 per share, converting $200,000 of debt.
• The total amount of debt converted to equity by Mr. Siokas across these four transactions is $349,000.
• The funds used for these acquisitions were personal funds and were not borrowed.
• Mr. Siokas has stated that he has no current plans or proposals that would result in significant changes to the issuer's corporate structure, business, or management.

Sentiment

Score: 6

Explanation: The CEO's increased beneficial ownership signals confidence and commitment, which is generally positive. However, the use of debt-for-equity conversions, especially with a declining effective share price, could indicate the company's need to conserve cash or manage its liabilities, which introduces a degree of financial uncertainty.

Positives

• The CEO, Grigorios Siokas, significantly increased his beneficial ownership to 16.6%, signaling strong confidence in Cosmos Health Inc.'s future prospects.
• The conversion of $349,000 in debt owed to the CEO into equity reduces the company's liabilities and strengthens its balance sheet.
• The acquisitions were funded by Mr. Siokas's personal funds, demonstrating direct financial commitment and alignment with shareholder interests.

Negatives

• The company's reliance on debt-for-equity conversions with its CEO could indicate liquidity challenges or an inability to repay cash debts.
• The declining effective share prices at which the debt was converted ($0.6613, $0.6451, $0.64, $0.5645) may suggest a low or decreasing valuation of the company's common stock at the time of the exchanges.

Risks

• Potential dilution for existing shareholders due to the issuance of new shares as part of the debt-for-equity conversions.
• Implied financial strain if the company is resorting to debt-for-equity swaps with its CEO instead of cash payments, which could signal underlying operational or cash flow issues.

Future Outlook

The reporting person, Grigorios Siokas, states that he has no current plans or proposals that would result in any of the matters listed in Item 4 of Schedule 13D, which include changes in control, mergers, asset sales, or other significant corporate actions.

Management Comments

• "There are no plans or proposals which the reporting person has which may result in any of the matters listed."
• "Personal funds, none of which have been borrowed."

Industry Context

This filing primarily details an insider's increased ownership through debt-for-equity conversions, which is a specific corporate finance mechanism. While not directly indicative of broad industry trends, debt-for-equity swaps can be a strategy employed by companies, particularly in sectors like healthcare or pharmaceuticals, to manage liabilities, conserve cash, and strengthen balance sheets, especially if they are in growth phases or facing specific financial pressures.

Related Party Transactions

• Grigorios Siokas, the CEO of Cosmos Health Inc., entered into four Debt Exchange Agreements with the company to convert $349,000 of debt owed to him into common stock. These transactions occurred on January 30, 2024, February 11, 2024, February 13, 2025, and February 24, 2025.

Stakeholder Impact

• Shareholders: Potential for dilution due to the issuance of new shares, but also a positive signal of confidence from the CEO's increased stake.
• Creditors: The reduction of debt owed to the CEO could be seen as a positive step for the company's balance sheet, though other creditors might scrutinize the company's liquidity if debt-for-equity swaps are necessary.
• Management: The CEO's increased equity stake further aligns his interests with the long-term performance of the company.

Key Dates

Recommendation

Keywords

Cosmos Health Inc., Schedule 13D, Grigorios Siokas, CEO, insider ownership, debt-for-equity, share acquisition, beneficial ownership, SEC filing, common stock, corporate finance